A1 Refereed original research article in a scientific journal

Decolonization of methicillin-resistant Staphylococcus aureus – effectiveness of decolonization treatment




AuthorsHaapia, Tiina; Vuopio, Jaana; Marttila, Harri; Silvola, Jaakko; Vahlberg, Tero; Kanerva, Mari; MRSA Study Group

PublisherCambridge University Press (CUP)

Publication year2025

Journal:Antimicrobial Stewardship & Healthcare Epidemiology

Article numbere234

Volume5

Issue1

eISSN2732-494X

DOIhttps://doi.org/10.1017/ash.2025.10070

Web address https://doi.org/10.1017/ash.2025.10070

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/504737160


Abstract

Objectives:

The aim of this study was to describe the efficacy of decolonization treatments given in Hospital District of Southwest Finland (HDSWF) in 2007–2016 and to analyze the key elements for successful decolonization treatment. Duration of follow-up varied from 12 to 15 months.

Methods:

All new MRSA cases detected between 2007 and 2016 in HDSWF (population 475,000) and their MRSA follow-up screening results within 12–15 months were retrospectively analyzed. This study focused on the outpatient carriers having received decolonization treatment during the study period.

Results:

Of the 983 MRSA cases detected during 2007–2016, 117 carriers went through decolonization treatment. Of those successfully followed up, 72/92 (78.3%) were successfully decolonized. Multisite carriage was a risk factor for unsuccessful decolonization.

Conclusion:

Decolonization treatment, including nasal mupirocin, chlorhexidine containing skin washes and in selected cases, also systemic antibiotics, was effective in outpatient settings, resulting in long-term clearance of the MRSA carriage.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
Open access funding provided by the University of Turku (UTU) including the Turku University Central Hospital. Dr. Sakari Alhopuro, M.D., Ph.D., is kindly thanked for financial support for this project. The work has also been supported by the Competitive State Research Financing of the Expert Responsibility area of the Turku University Hospital (M3016) for J.V. and by a grant from the Infectious Diseases Specialists’ Society and the Turku University Hospital for T.H.


Last updated on 2025-23-10 at 10:44